Literature DB >> 16818776

The histone methyltransferase Suv39h1 increases class switch recombination specifically to IgA.

Sean P Bradley1, Denise A Kaminski, Antoine H F M Peters, Thomas Jenuwein, Janet Stavnezer.   

Abstract

Ab class (isotype) switching allows the humoral immune system to adaptively respond to different infectious organisms. Isotype switching occurs by intrachromosomal DNA recombination between switch (S) region sequences associated with C(H) region genes. Although isotype-specific transcription of unrearranged (germline) C(H) genes is required for switching, recent results suggest that isotype specificity is also determined by the sequences of downstream (acceptor) S regions. In the current study, we identify the histone methyltransferase Suv39h1 as a novel Salpha-specific factor that specifically increases IgA switching (Smu-Salpha recombination) in a transiently transfected plasmid S substrate, and demonstrate that this effect requires the histone methyltransferase activity of Suv39h1. Additionally, B cells from Suv39h1-deficient mice have an isotype-specific reduction in IgA switching with no effect on the level of germline Ialpha-Calpha transcripts. Taken together, our results suggest that Suv39h1 activity inhibits the activity of a sequence-specific DNA-binding protein that represses switch recombination to IgA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818776     DOI: 10.4049/jimmunol.177.2.1179

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

Review 2.  Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination.

Authors:  Jeremy A Daniel; André Nussenzweig
Journal:  Biochim Biophys Acta       Date:  2012-02-12

3.  Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.

Authors:  Andrew W Lindsley; Howard M Saal; Thomas A Burrow; Robert J Hopkin; Oleg Shchelochkov; Pooja Khandelwal; Changchun Xie; Jack Bleesing; Lisa Filipovich; Kimberly Risma; Amal H Assa'ad; Phillip A Roehrs; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol       Date:  2015-07-17       Impact factor: 10.793

4.  A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse.

Authors:  Gunnar Schotta; Roopsha Sengupta; Stefan Kubicek; Stephen Malin; Monika Kauer; Elsa Callén; Arkady Celeste; Michaela Pagani; Susanne Opravil; Inti A De La Rosa-Velazquez; Alexsandra Espejo; Mark T Bedford; André Nussenzweig; Meinrad Busslinger; Thomas Jenuwein
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

5.  H3 trimethyl K9 and H3 acetyl K9 chromatin modifications are associated with class switch recombination.

Authors:  Fei Li Kuang; Zhonghui Luo; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

6.  Lysine methylation of nuclear co-repressor receptor interacting protein 140.

Authors:  M D Mostaqul Huq; Sung Gil Ha; Helene Barcelona; Li-Na Wei
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

Review 7.  Mechanism and regulation of class switch recombination.

Authors:  Janet Stavnezer; Jeroen E J Guikema; Carol E Schrader
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 8.  The AID-induced DNA damage response in chromatin.

Authors:  Jeremy A Daniel; André Nussenzweig
Journal:  Mol Cell       Date:  2013-05-09       Impact factor: 17.970

Review 9.  Epigenetics of the antibody response.

Authors:  Guideng Li; Hong Zan; Zhenming Xu; Paolo Casali
Journal:  Trends Immunol       Date:  2013-05-02       Impact factor: 16.687

10.  Analysis of intergenic transcription and histone modification across the human immunoglobulin heavy-chain locus.

Authors:  Muslima Chowdhury; Omid Forouhi; Sandeep Dayal; Natalie McCloskey; Hannah J Gould; Gary Felsenfeld; David J Fear
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.